ArticleDermatology practical & conceptual2018
New trends in botulinum toxin use in dermatology.
Article in Dermatology practical & conceptual, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 26 citations in OpenAlex.
- Observing Picomolar Protein Unfolding Using Resonance Light Scattering.Biomolecules · 2025Article
- Model-based interspecies interpretation of botulinum neurotoxin type A on muscle-contraction inhibition.Biopharmaceutics & drug disposition · 2024Article
- Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.Archives of toxicology · 2022Review
- Immunogenicity of botulinum toxin.Archives of plastic surgery · 2022Article
- Botulinum Toxin: An Effective Treatment for Flushing and Persistent Erythema in Rosacea.The Journal of clinical and aesthetic dermatology · 2021Article
- Utilities of Botulinum Toxins in Dermatology and Cosmetology.Clinical, cosmetic and investigational dermatology · 2021Review
- Skin Quality - A Holistic 360° View: Consensus Results.Clinical, cosmetic and investigational dermatology · 2021Article
- Comparative Pharmacodynamics Study of 3 Different Botulinum Toxin Type A Preparations in Mice.Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2020Article
- Botulin Toxin Use in Scars/Keloids Treatment.Open access Macedonian journal of medical sciences · 2019Review
- Botulin Toxin Use in Rosacea and Facial Flushing Treatment.Open access Macedonian journal of medical sciences · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRecent studies have highlighted new botulinum neurotoxin (BoNT) applications in the field of dermatology.
objectiveTo review current knowledge of BoNT use in dermatology.
methodsThe literature of the last 5 five years has been reviewed.
resultsWe describe interesting protocols of BoNT treatment for hyperhidrosis (HH), hypertrophic scars and keloids, Raynaud phenomenon, facial flushing, oily skin, psoriasis, Hailey-Hailey disease, and cutaneous lesions like painful lesions and periorbital syringomas.
conclusionsSeveral skin conditions eligible for BoNT treatment have been described. After the wide application for HH treatment, scars as well as vascular and inflammatory skin disorders, oily skin and cutaneous lesions represent fields of application of BoNT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.